The Premier Meeting Across all Stakeholders in Immuno-Oncology
The 9th annual Immuno-Oncology 360° Summit offers an unparalleled opportunity to hear from stakeholders representing both the science and business communities who report on the latest data impacting IO.
Keynotes include:
– Dr Carolyn Bertozzi, Stanford University on Bioorthogonal and Click Chemistries Impact on Advancing Cancer Immunotherapy
– Dr Marcela Maus, Massachusetts General Hospital on Mechanisms Driving CAR T Cells
– Dr Isabelle Rivière, Memorial Sloan Kettering Cancer Center on Cell Therapy Manufacturing Progress Report and Novel Manufacturing Paradigms
– Dr Axel Hoos, Scorpion Therapeutics on Transformational Medicines & The Next Wave of IO
– Dr Andrew Baum, Citi on What’s Next on the IO Radar? Top 10 Recommendations
– Dr Arjun Goyal, Vida Ventures on Investor Perspective on the State of the Current Market and Impact on the IO Cell Therapy Field
– Oswald Peterson,Stage IV Lung Cancer Survivor who will share his extraordinary story from diagnosis through to immunotherapy treatments that saved his life
Plenary Topics include:
– Cell Therapy
– Biomarkers / Assay Development
– Discovery / Preclinical
– Imaging Advancements
– Clinical Operations
– Business Developments
– Translational Science
– RNA Therapeutics
– Clinical Developments
The conference includes a multitude of networking opportunities including 1:1 partnering meetings, exhibit hall access, receptions, and optional evening activities such as historic walks of downtown Brooklyn.
15% Discount with Code ARM15
Location: New York Marriott at the Brooklyn Bridge
333 Adams Street
Brooklyn, New York 11201
